Come up with a name for your new list and we'll add to it:
Emmaus Life Sciences raised a round of funding on January 18, 2018. Investors include
GPB Capital Holdings.
Emmaus Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan disease. The compan…